These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Hormonal and renal interaction in body fluid regulation in the newborn infant. Siegel SR Clin Perinatol; 1982 Oct; 9(3):535-57. PubMed ID: 6761037 [No Abstract] [Full Text] [Related]
28. Interaction of kinins and captopril in regulating arterial smooth muscle cell proliferation. Dixon BS; Dennis MJ Kidney Int Suppl; 1997 Oct; 61():S14-7. PubMed ID: 9328956 [No Abstract] [Full Text] [Related]
29. Kinins, renal function and blood pressure regulation. Introduction. McGiff JC; Nasjletti A Fed Proc; 1976 Feb; 35(2):172-4. PubMed ID: 1248652 [No Abstract] [Full Text] [Related]
31. Kallikreins, kinins and cardiovascular diseases: a short review. Margolius HS Biol Res; 1998; 31(3):135-41. PubMed ID: 9830500 [TBL] [Abstract][Full Text] [Related]
32. Vasodepressor hormones in hypertension: prostaglandins and kallikrein-kinins. Satellite symposium to the meeting of the International Society of Hypertension. Nuremberg, 1986. Proceedings. Agents Actions Suppl; 1987; 22():1-390. PubMed ID: 3481206 [No Abstract] [Full Text] [Related]
33. Fibrinolysin system and vasoactive kinins. Back N Fed Proc; 1966; 25(1):77-83. PubMed ID: 4283649 [No Abstract] [Full Text] [Related]
34. [Kinins--characteristics and role in the circulatory system]. Gabrylewicz B; Tendera M Pol Merkur Lekarski; 2004 Dec; 17(102):547-9. PubMed ID: 15771118 [TBL] [Abstract][Full Text] [Related]
35. Transporting epithelia as targets for kinin effects. Cuthbert AW; MacVinish LJ Adv Exp Med Biol; 1986; 198 Pt A():203-10. PubMed ID: 3643706 [No Abstract] [Full Text] [Related]
36. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy. Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811 [TBL] [Abstract][Full Text] [Related]
37. [Effect of the kallikrein-kinin system on gastric function]. Vovchuk SV; Kolenda IuV; L'vov IF; Levitskiĭ AP; Synovets AS Fiziol Zh (1978); 1983; 29(5):609-15. PubMed ID: 6357865 [No Abstract] [Full Text] [Related]
38. Kinins, receptors, kininases and inhibitors--where did they lead us? Erdös EG; Marcic BM Biol Chem; 2001 Jan; 382(1):43-7. PubMed ID: 11258670 [TBL] [Abstract][Full Text] [Related]
39. Effects of an orally active converting enzyme inhibitor (YS-980) on renal function in dogs. Abe Y; Miura K; Imanishi M; Yukimura T; Komori T; Okahara T; Yamamoto K J Pharmacol Exp Ther; 1980 Jul; 214(1):166-70. PubMed ID: 6156237 [TBL] [Abstract][Full Text] [Related]
40. Tissue kallikreins and kinins: roles in human disease and target for new drug development. Margolius HS Adv Exp Med Biol; 1989; 247A():1-6. PubMed ID: 2690583 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]